2024 - Navigating the CNS Clinical Trial Landscape in the Asia-Pacific (APAC): Challenges, Opportunities, and Best Practices

The Asia-Pacific (APAC) region is emerging as a pivotal contributor to the global central nervous system (CNS) trials ecosystem. Driven by increased investments from global pharmaceutical companies, APAC has demonstrated significant regional growth with estimates suggesting a compound annual growth rate of around eight to 10 percent across the next few years.
Success in this diverse and rapidly evolving market hinges on overcoming many challenges including standardization, cultural differences, localization, rater identification & training, technology, data accuracy and more.
In this webinar, CNS trial experts from Cogstate — including those native to the region — will delve into the complexities of conducting CNS trials in APAC, focusing on the delicate balance between achieving standardized, high-quality data collection and minimizing cultural bias through consideration of local cultural-linguistic nuances.
Panelists will explore the rising demand for CNS studies in APAC and key factors that drive the region’s appeal for clinical trial teams. The session will focus on addressing regional challenges in CNS endpoint assessment, rater training & monitoring, decentralized trial methodologies and operational considerations and provide practical solutions to overcome hurdles and support high quality data capture in trials with an APAC footprint. Specific case examples from Japan and China will be presented.
Join this webinar to gain a deeper understanding of successfully executing CNS trials in the dynamic APAC region.
Keywords: China, Japan, Clinical Research, CRO, Central Nervous System, Global Clinical Trials, Clinical Trials in Asia, CNS, APAC, Asia-Pacific, CNS Trials, Asia Clinical Trials, Decentralized Trials, Decentralized Clinical Trials, Clinical Trials in China